NDC 67296-2153-01 - Benzonatate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67296-2153
- Requested NDC
- 67296-2153-01
- Package NDCs from labels
- 67296-2153-1, 67296-2153-3, 67296-2153-01
- Manufacturer
- Redpharm Drug
- Effective date
- 2025-12-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Benzonatate - Redpharm Drug | Redpharm Drug | 2025-12-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67296-2153-1 | Benzonatate | 15 in 1 BOTTLE | CAPSULE | 15 | 5 | |
| 67296-2153-3 | Benzonatate | 30 in 1 BOTTLE | CAPSULE | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67296-2153 | BENZONATATE CAPSULE [REDPHARM DRUG] | 2 | Current NDC, 2 package rows | 20250410_32524a8a-4cee-26c0-e063-6294a90aa898.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Artificial Tears Lubricant Eye Drops | GLYCERIN, PROPYLENE GLYCOL | CVS Pharmacy | 28297fee-8185-4869-8f39-5bfbf8bf8bfd | 2026-04-13 | Warnings | PDC6A3C0OX |
| blink boost | GLYCERIN | Bausch & Lomb Incorporated | e765c224-1718-488f-99b2-976eb60c1d63 | 2026-04-13 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream with Lidocaine | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 4f1ef866-c4af-989b-e063-6294a90a148e | 2026-04-10 | Warnings | PDC6A3C0OX |
| Benzonatate 100 mg | BENZONATATE 100 MG | MARKSANS PHARMA LIMITED | 44104cfc-df60-4d48-9fe1-53456a5e1974 | 2026-04-10 | Warnings, Adverse reactions | 197397 283417 5P4DHS6ENR |
| WE FRESH Lubricating Eye Drops | GLYCERIN | Oculus Surgical, Inc. | 4f253b5d-001b-091e-e063-6394a90a9d39 | 2026-04-09 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | Walgreens | 1e845299-178e-49ce-9d08-7e9d548a5a6d | 2026-04-09 | Warnings | PDC6A3C0OX |
| Benzonatate | BENZONATATE | Sportpharm LLC | 0e8f2562-2449-430f-85bb-f9195644cdfa | 2026-04-07 | Warnings, Adverse reactions | 197397 283417 5P4DHS6ENR |
| Thera Plus Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Fourstar Group USA, Inc. | 5d63bf97-29d2-4c71-97c3-85f425e86207 | 2026-04-07 | Warnings | PDC6A3C0OX |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| Redness Relief | GLYCERIN, NAPHAZOLINE HCL | Pharmadel LLC | 4c113bb9-814f-d92d-e063-6294a90a8302 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Moisture Oyster | GLYCERIN | Moisture Oyster Inc | 4e45317a-437f-4d88-e063-6294a90a98d0 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Aveeno Skin Relief Healing | GLYCERIN | Kenvue Brands LLC | 345fdde5-700b-7103-e063-6394a90a0e3e | 2026-03-27 | Warnings | PDC6A3C0OX |
| Crocodile Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Crocodile Tears LLC | 4df29336-ea0c-0484-e063-6294a90a685a | 2026-03-26 | Warnings | PDC6A3C0OX |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | KC Pharmaceuticals, Inc | 4de5c844-85ca-ff9f-e063-6394a90ac12c | 2026-03-25 | Warnings | PDC6A3C0OX |
| Lemon Glycerin | GLYCERIN | Dynarex Corporation | 99fc00ea-9d55-0380-e053-2995a90a2c0b | 2026-03-24 | Warnings | PDC6A3C0OX |
| Benzonatate | BENZONATATE | Zydus Pharmaceuticals USA Inc. | 331c70dc-005e-4d96-a35c-4d2d810aa3b1 | 2026-03-23 | Warnings, Adverse reactions | ANDA040597 68382-091 197397 283417 00b5fd87-d6cb-4a95-b835-4e9c1232768b 331c70dc-005e-4d96-a35c-4d2d810aa3b1 5P4DHS6ENR |
| Benzonatate | BENZONATATE | Preferred Pharmaceuticals Inc. | 6f7f4a31-99ec-45ca-84d7-0be3640d1e0b | 2026-03-19 | Warnings, Adverse reactions | ANDA040597 283417 5P4DHS6ENR |
| Benzonatate | BENZONATATE | Preferred Pharmaceuticals Inc | 3309040d-e240-42f6-9c51-5c54604a3896 | 2026-03-19 | Warnings, Adverse reactions | 197397 5P4DHS6ENR |
| Benzonatate | BENZONATATE | Preferred Pharmaceuticals Inc. | f2cd05a6-2b8b-4731-b97b-b6677fbabbcf | 2026-03-19 | Warnings, Adverse reactions | 283417 5P4DHS6ENR |
| Benzonatate | BENZONATATE | Preferred Pharmaceuticals, Inc. | fe5e8a94-ac75-4657-a45a-1fe94dbe0d43 | 2026-03-19 | Warnings, Adverse reactions | 283417 5P4DHS6ENR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.